80
Participants
Start Date
January 14, 2024
Primary Completion Date
December 18, 2025
Study Completion Date
June 18, 2026
CD19&CD20 bispecific CAR-T cells
Each patient will receive CD19\&CD20 bispecificCAR-T cells by intravenous infusion on day 0.
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Hebei Taihe Chunyu Biotechnology Co., Ltd
INDUSTRY
Zhujiang Hospital
OTHER
Jingzhou Central Hospital
OTHER
Shiyan People's Hospital
UNKNOWN
Xiangyang Central Hospital
OTHER
Yichang Central People's Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER